We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

75 hedge funds and large institutions have $143M invested in Immunomedics Inc in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

1% less capital invested

Capital invested by funds: $145M → $143M (-$2M)

7% less funds holding

Funds holding: 8175 (-6)

34% less call options, than puts

Call options by funds: $4.33M | Put options by funds: $6.57M

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
75
Holders Change
-6
Holders Change %
-7.41%
% of All Funds
2.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
27
Reduced
18
Closed
14
Calls
$4.33M
Puts
$6.57M
Net Calls
-$2.25M
Net Calls Change
-$1.71M
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$509K +$599K +120,792 New
CS
27
Credit Suisse
Switzerland
$480K +$102K +20,503 +22%
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$433K
Allianz Asset Management
29
Allianz Asset Management
Germany
$421K
Morgan Stanley
30
Morgan Stanley
New York
$409K -$42.7K -8,611 -8%
OC
31
Oppenheimer & Co
New York
$392K +$33.9K +6,840 +8%
Prudential Financial
32
Prudential Financial
New Jersey
$378K -$122K -24,700 -22%
Barclays
33
Barclays
United Kingdom
$373K +$292K +58,803 +172%
Swiss National Bank
34
Swiss National Bank
Switzerland
$371K +$99.7K +20,100 +30%
AQR Capital Management
35
AQR Capital Management
Connecticut
$349K +$132K +26,600 +47%
Goldman Sachs
36
Goldman Sachs
New York
$321K -$11.7K -2,357 -3%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$270K -$17.8K -3,580 -5%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$260K
MLICM
39
Metropolitan Life Insurance Company (MetLife)
New York
$258K
Deutsche Bank
40
Deutsche Bank
Germany
$250K +$143K +28,763 +93%
NFA
41
Nationwide Fund Advisors
Ohio
$237K -$3.48K -701 -1%
BA
42
BlackRock Advisors
Delaware
$233K +$23.2K +4,686 +9%
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$217K +$22.3K +4,500 +10%
Citadel Advisors
44
Citadel Advisors
Florida
$216K -$994K -200,499 -80%
Citigroup
45
Citigroup
New York
$213K +$41.4K +8,357 +20%
AIG
46
American International Group
New York
$210K +$5.94K +1,197 +2%
Public Employees Retirement Association of Colorado
47
Public Employees Retirement Association of Colorado
Colorado
$203K
BG
48
BlackRock Group
United Kingdom
$144K
UBS AM
49
UBS AM
Illinois
$130K +$29.3K +5,900 +24%
FHC
50
First Heartland Consultants
Missouri
$129K

IMMU Hedge Fund Activity: Q1 2014 in Review

75 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2014, worth a combined $143M — down 1.4% from $145M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of IMMU and 8 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 27 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $13M. The largest seller was SAC Capital Advisors, exiting entirely with an estimated $6.43M sold.

  • 75 institutional investors held Immunomedics Inc (IMMU) as of Q1 2014, down from 81 in Q4 2013.
  • Funds reported $143M of Immunomedics Inc stock for Q1 2014, down 1.4% quarter-over-quarter.
  • 8 funds opened new Immunomedics Inc positions in Q1 2014 and 14 closed out, a net change of -6 holders.
  • The largest Immunomedics Inc buyer in Q1 2014 was Deerfield Management, an estimated $13M added.
  • The largest Immunomedics Inc seller in Q1 2014 was SAC Capital Advisors, an estimated $6.43M sold.

Based on aggregated 13F filings for Q1 2014.